Therapy News and Research

RSS

Stereotaxis completes 50 clinical procedures with new Niobe ES system to treat cardiac arrhythmias

Stereotaxis, Inc. today announced the completion of the first 50 clinical procedures using the Company's new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia.

11 Jan 2012

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

Pulmonx SARL today announced that its European notified body has granted CE approval for expanded labeling of its Zephyr endobronchial valve.

11 Jan 2012

ADHD diet: Review of studies

A new review finds that some foods may not be good for children with attention deficit-hyperactivity disorder (ADHD). Fast foods, red meat, processed foods, soft drinks, high fat dairy foods and potato chips may not be right.

10 Jan 2012

Questions raised over nicotine replacement therapy: Study

Smokers have been advised a host of choices for nicotine replacement like gums, patches and nasal sprays to help them quit. But a new U.S. study says that these do not help people quit cigarettes over the long term any better than going it alone.

10 Jan 2012

Concerns over using ARV therapy as prevention strategy

PSI's "Healthy Lives" blog reviews a recent Science magazine article written by James Shelton of USAID's Bureau of Global Health in which he raises concerns about the use of antiretroviral drugs (ARVs) as a prevention strategy.

10 Jan 2012

Cardio3BioSciences raises €3.1M in non-dilutive funding

The Belgian biotechnology company, Cardio3BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces it has secured a total of €3.1 million in non-dilutive funding from the Walloon Region and the European Commission's Seventh Framework Programme.

10 Jan 2012

Study confirms safety and effectiveness of rAHF-PFM in managing hemophilia A

A Rush University Medical Center led international research team has announced that a treatment to prevent bleeding episodes in children with hemophilia A also is effective for adolescents and adults.

10 Jan 2012

TCM therapy makes fertility treatments far more effective: Study

Traditional Chinese medicine has long been used to ease pain, treat disease, boost fertility, and prevent miscarriage. Known in the Western medical community by its acronym TCM, these traditional remedies include herbal preparations and acupuncture. Now Tel Aviv University researchers have discovered that a combination of TCM therapy and intrauterine insemination (IUI) is a winning solution for hopeful mommies who are having trouble conceiving.

10 Jan 2012

Researchers create prostate cancer drug delivery system

Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.

10 Jan 2012

Personalized therapies may improve survival and QoL of patients with glioblastoma

Personalized prognostic tools and gene-based therapies may improve the survival and quality of life of patients suffering from glioblastoma, an aggressive and deadly form of brain cancer, reports a new University of Illinois study funded by the NIH National Cancer Institute.

10 Jan 2012

Insulin induces formation of new elastin in cultures of human aortic smooth muscle cells

New research reveals that insulin applied in therapeutic doses selectively stimulates the formation of new elastic fibers in cultures of human aortic smooth muscle cells.

10 Jan 2012

Amylin outlines key strategic priorities for 2012

Amylin Pharmaceuticals, Inc. today outlined its key strategic priorities for 2012, with a strong focus on driving the global commercial value of its diabetes franchise.

10 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Sangamo BioSciences, Inc. announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS.

9 Jan 2012

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.

9 Jan 2012

TRON uses Ingenuity Variant Analysis to identify cancer driver variants

Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced that TRON has used Ingenuity Variant Analysis to identify cancer driver variants that inform the development of an experimental individualized RNA-based therapeutic.

9 Jan 2012

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

SFJ Pharma Ltd. II announced today that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy.

9 Jan 2012

Therapy News and Research

Stereotaxis completes 50 clinical procedures with new Niobe ES system to treat cardiac arrhythmias

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

ADHD diet: Review of studies

Questions raised over nicotine replacement therapy: Study

Concerns over using ARV therapy as prevention strategy

Cardio3BioSciences raises €3.1M in non-dilutive funding

Study confirms safety and effectiveness of rAHF-PFM in managing hemophilia A

TCM therapy makes fertility treatments far more effective: Study

Researchers create prostate cancer drug delivery system

Personalized therapies may improve survival and QoL of patients with glioblastoma

Insulin induces formation of new elastin in cultures of human aortic smooth muscle cells

Amylin outlines key strategic priorities for 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

TRON uses Ingenuity Variant Analysis to identify cancer driver variants

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

Scientists identify key tumorigenic pathways in never-smoker lung adenocarcinoma patients

Middle-aged adults with diabetes have time to learn how to control hypertension

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News